The male sex hormone system is a fascinating and unique aspect of human biology. While it may seem more straightforward than the female system, it still has nuances that make studying enjoyable. One of the critical features of this system is the upstream regulation at the hypothalamus, where GnRH signals the pituitary gland to release LH and FSH. These hormones then signal the testes to produce testosterone.
Testosterone is primarily bound to sex hormone-binding globulin (SHBG) and albumin, with only a tiny amount remaining free and unbound. Some testosterone is siphoned off to produce dihydrotestosterone (DHT) and estradiol. DHT is a potent sex hormone with a higher binding affinity for the androgen receptor than testosterone. At the same time, estrogen is crucial in male mood, body composition, and bone mineral density.
The feedback loop in the male sex hormone system is crucial for maintaining a balance of hormones. Rising testosterone levels inhibit the hypothalamus and pituitary, which slows down GnRH and LH/FSH production. Estrogen also inhibits LH secretion via the pituitary.
Testosterone replacement therapy (TRT) is a standard treatment for low testosterone or Androgen Deficiency in Aging Males (ADAM). TRT involves giving testosterone in various formats, such as topical or injectable. However, there are complexities in measuring testosterone levels, as free testosterone is a calculated lab value, and the number of androgen receptors a person has is unknown. Symptoms of low testosterone can include low libido, erectile dysfunction, low mood, difficulty building muscle mass, and insulin resistance.
While TRT can have many benefits, caution is necessary as it is often overused and not always needed for treating low testosterone. Treatment should be based on symptoms, and other factors, such as free testosterone and androgen receptor saturation, should be considered. Direct and indirect methods can be used for TRT, including pellets and topical formulations.
The male sex hormone system is a complex and fascinating aspect of human biology that underscores the importance of hormone balance and optimization for overall health and well-being.
*****
*****
Summary of Transcript:
This video discusses the male sex hormone system, which starts with the hypothalamus releasing GnRH, which prompts the pituitary gland to release LH and FSH. These hormones then stimulate the testes to produce testosterone, primarily binding to sex hormone-binding globulin (SHBG) and albumin. Some testosterone is converted into dihydrotestosterone (DHT) by the enzyme 5 alpha-reductase and estrogen by the aromatase enzyme. DHT has a higher binding affinity to the androgen receptor than testosterone, and estrogen is essential for mood, body composition, and bone mineral density in men. Testosterone therapy is complicated due to the uncertainty about the number of androgen receptors a person has and whether they are saturated with testosterone or DHT. Symptoms of low testosterone include low libido, erectile dysfunction, low mood, difficulty putting on muscle mass, and insulin resistance. Testosterone therapy can take the form of topical or injectable applications, or indirect methods can be used to stimulate testosterone production. As testosterone therapy is overused, caution is necessary for a prescription.
*****
Summary of Description:
The content provides an overview of male sex hormones from a segment of The Drive podcast. The episode explores various health topics, including nutritional biochemistry, Alzheimer’s disease, cancer, and mental health. The podcast is part of Peter Attia’s health and wellness platform, Early Medical, which aims to lengthen lifespan and improve healthspan through the principles of Medicine 3.0. The podcast is for general informational purposes and should not be considered a substitute for professional medical advice. Users should consult with healthcare professionals for any medical conditions they have.
*****
Source Description
Peter provides a comprehensive overview of the male sex hormones. This video is a segment from The Drive podcast Episode 256 – The endocrine system: exploring thyroid, adrenal, and sex hormones. The full video can be found here: https://www.youtube.com/watch?v=5oxFK6poSXM.
Watch the full episode and view show notes here: https://bit.ly/432u3eB
Become a member to receive exclusive content: https://peterattiamd.com/subscribe/
Sign up to receive Peter’s email newsletter: https://peterattiamd.com/newsletter/
——–
About:
The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity and all that goes into that, from physical to cognitive to emotional health. With over 60 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and more.
Peter Attia is the founder of Early Medical. This medical practice applies the principles of Medicine 3.0 to patients to lengthen their lifespan and simultaneously improve their healthspan.
Learn more: https://peterattiamd.com.
Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG
Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle
Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. Using this information and the materials linked to this podcast is at the user’s risk. The content on this podcast is not intended to substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website, where I keep an up-to-date and active list of such companies.
